MT-2301

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-2301, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Clinical Study of MT-2301 [Phase 2]